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556a Wednesday, February 6, 2013monofunctional, being capable of only the adenylation of FMN to form FAD.
Studies on bacterial FADS have shown considerable promiscuity in the accep-
tance of altered FMNs as substrates but absolutely no uptake of different nucle-
otide triphosphates (e.g. CTP, TTP, etc.).
Here we show that bacterial FADS (from C. ammoniagenes, CaFADS) will ac-
cept a modified ATP analog, specifically the fluorescent ATP analog aminopur-
ine-2’-deoxyriboside-5’-triphosphate (2ApTP) for the production of dual
fluorescent F-2Ap-D. Surprisingly, preliminary experiments indicate the mono-
functional hFADS is not similarly promiscuous. These results implicate that
this difference in substrate specificity may lead to unique biomarker applica-
tions. Understanding these enzymes may also lead to new approaches in nucle-
oside analog therapeutics.
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Lung collectin surfactant proteins are pulmonary host defense proteins that
contribute to innate, front-line defense against influenza A virus (IAV) and
other inhaled pathogens. Effective pulmonary host defense requires fast recog-
nition by lung surfactant protein D (SP-D) of glycans on the globular head of
IAV hemagglutinin (HA), thereby initiating events leading to pathogen neutral-
ization. In site-directed mutagenesis experiments, a double mutant of human
SP-D, namely R343V/D325A, was found to enhance IAV neutralization activ-
ity. In order to understand the effect of the double mutation on the mechanism
of SP-D recognition and inhibition of IAV HA, we performed molecular dy-
namics simulations on docked SP-D-HA complexes for wild type SP-D
(wtSP-D) and double mutant SP-D (dmSP-D). Our simulations revealed that
side chain properties of the mutated residues and modes of glycan binding
lead to increased binding affinity of dmSP-D to the active site of IVA HA, in-
creasing thereby its antiviral activity.
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Druggability assessment of a target protein is an important concept in drug dis-
covery. Target flexibility and allostery poses challenges to structure based bind-
ing site identification and druggability assessment methods. We developed
a simulation-based methodology for comprehensive analysis of the dynamics
and binding properties of target proteins (1). Two distinguishing features of
the methodology are: (i) simulation of the target in presence of a diversity of
probe molecules selected upon analyzing functional groups on approved drugs,
(ii) identification of druggable sites and estimation of corresponding maximal
affinities based on the geometry and energetics of bound probe clusters. The
use of the methodology for a variety of targets such as PTP1B, lymphocyte
function-associated antigen 1, and vertebrate kinesin-5 (Eg5) provides shows
that the method correctly captures the location and maximal affinities known
bindings sites. It also provides insights into the target’s structural changes
that would accommodate, if not promote and stabilize, drug binding (2). Nota-
bly, the ability to identify high affinity spots even in challenging cases such as
PTP1B or Eg5 shows promise as a rational tool for assessing the druggability of
protein targets, and identifying novel allosteric sites for drug binding. A thor-
ough case study of cytochrome (cyt) c druggability provides further support to
the utility of the methodology for prospective targets with limited structural
data. We identified the pocket facing heme and accessible in the partially un-
folded form of cyt c as a sub-nanomolar druggable site. The first ever pharma-
cophore model developed for cyt c based on these simulations can distinguish
known heme binders and is being advantageously used for discovering new
drug-like inhibitors of cyt c.
1. Bakan A et al. J Chem Theory Comput. 2012 8(7):2435-47.
2. Bakan A, Bahar I. PNAS 2009 106(34):14349-54.
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2Universita` di Trieste, Trieste, Italy, 3T&B associati srl, Trieste, Italy.We present a method to design small peptides able of high affinity binding with
a preselected target molecule. Our algorithm builds on a combination of molec-
ular dynamics, semi-flexible docking and replica exchange Monte Carlo, and
performs simultaneous sampling in sequence and conformational spaces care-
fully selecting the degree of flexibility in the mutated peptides. The approach is
used to design a decapeptide able to bind the anti-HIV drug efavirenz. The cal-
culated binding energy of the designed peptide (approx. 12 kcal/mol) was
confirmed experimentally by fluorescence measurements. NMR spectroscopy
confirmed the interactions between the peptide and the efavirenz molecule pre-
dicted by the algorithm.
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Protein Kinase G (PKG) is a second messenger dependent protein implicated in
smooth muscle relaxation. Active PKG signals for blood vessel dilation, mak-
ing it an attractive target in cardiovascular drug discovery. The PKG regulatory
domain consists of two, potentially druggable, cyclic nucleotide binding do-
mains (CNBDs), which activate PKG when simultaneously occupied by
cGMP. Here we contribute to the characterization of each CNBD by examining
its ability to discriminate between cGMP and a highly similar ligand, cAMP.
Relative binding free energies were calculated using molecular dynamic simu-
lations and thermodynamic integration (TI). The contribution of individual res-
idues was assessed by repetition over a series of mutant structures. In some
cases, multiple ligand binding conformations (syn vs. anti about the glycosyl
bond) were found to meaningfully contribute to the binding free energies. As
the barrier to rotation between these conformations prevented adequate sam-
pling on computationally feasible TI timescales, the confine-and-release
method was used to account for the contribution of each conformation. This re-
sulted in improved convergence and agreement with experiment.
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Functional protein-protein interactions are essential formany physiological pro-
cesses andmay play important roles in substrate channeling, coenzyme transfer,
and compartmentation in glycolysis. Herein, Brownian dynamics (BD) eluci-
dates the interactions between the glycolytic enzymes glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and lactate dehydrogenase (LDH) and
the transfer of the cofactor nicotinamide adenine dinucleotide (NAD) between
LDH and GAPDH. BD channeling simulation results strongly depend on choice
of reactive atom set. When the reactive atoms set comprise of atoms in the
vicinity of the NAD binding site of either enzyme, short NAD trajectories
between enzyme subunits occur. If the reactive atoms set were chosen from
atoms belonging to NAD binding sites, the efficiency of reaching LDH
decreased significantly, and even the shortest trajectories spent time equilibrat-
ing with solvent before binding the next active site. Transfer of NAD from
GAPDH to LDH is sensitive to overall structure of enzyme-enzyme complex.
Small variations in orientation of one enzyme relative to the other cause changes
in channeling efficiency. The process of NAD release from GAPDH and LDH
binding sites was studied with steered molecular dynamics. The GAPDH/LDH
complex with two LDH subunits facing two GAPDH subunits was chosen as
initial structure. Six NADmolecules were included - two molecules in GAPDH
active subunits and 4 NAD molecules bound to each LDH subunit. External
forces were applied to O3 NAD atom of each NAD molecule. MD trajectories
(2 ns) with external force (% 1000 pN) were able to pull the NAD out of
GAPDH, but not out of LDH. Such strong binding of NAD by LDH is because
the nicotinic moiety is buried deep inside LDH subunit globule. Additional
studies are needed to confirm the hypothesis that intermolecular contacts soften
GAPDH subunit and its affinity to NAD reduces.
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Riboflavin ligands present an alternative pathway for targeted drug delivery as
riboflavin receptors are over-expressed in breast and prostate cancer cells. We
have examined a riboflavin conjugated PAMAM dendrimer (generation 5) for
Wednesday, February 6, 2013 557atargeting riboflavin binding protein (RFBP), which acts as a model protein for
the riboflavin receptor. By characterizing the binding interactions between ri-
boflavin dendrimer gold nanoparticle conjugates and RFBP, the efficacy of
this platform for a targeted approach of drug delivery can be predicted more
accurately. Atomic Force Microscopy (AFM) was used for biological imaging
studies of these riboflavin-dendrimer complexes conjugated with gold-
nanoparticles. using a systematic ‘‘building block’’ approach, the size distribu-
tion of riboflavin dendrimer gold nanoparticle conjugates was mapped.
Changes in height upon binding to RFBP and subsequent removal by compet-
itive binding ligands demonstrate that this method could present a novel ap-
proach to screening the binding of drugs to drug targets.
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Importin-beta plays an important role in material exchange between the cell nu-
cleus and the cytoplasm. In order to transport large molecules through the nu-
clear pore complex it has to bind tightly to the importin-beta-binding (IBB)
domain of its cargo.
To probe the mechanical properties of this binding, enforced unbinding was in-
vestigated by single molecule atomic force microscopy (AFM) experiments in
which the cargo was pulled out of the complex. To structurally characterize the
unfolding pathway, we have performed force probe molecular dynamics (MD)
simulations at different constant loading rates on the importin-beta/IBB domain
complex.
Depending on the applied loading rate, three different unbinding pathways
were observed. using time dependent rate theory, these pathways were charac-
terized in terms of the rupture rate, rupture length and the barrier height of the
complex, which allow direct comparison with AFM data.
We hypothesize that the elastic properties of the involved proteins control bind-
ing and unbinding of this complex.
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ADP-glucose pyrophosphorylase (ADP-Glc PPase) is the regulatory enzyme of
the pathway for starch synthesis in plants and glycogen in mammals and enteric
bacteria. It exists as a 200 kDa homotetramer (a4) in enteric bacteria, and as
a heterotetramer (a2b2) in plants. In both in vivo and in vitro the substrates
(Glucose 1-Phosphate; Glc-1P and Adenosine 5’-Triphosphate; ATP) are con-
verted into a glucose donor ADP-Glucose and a pyrophosphate (PPi) via the
ADP-Glc PPase enzyme. It has been noted that some residues are conserved
in homotetrameric bacterial ADP-Glc PPases, but are not in some plant forms.
One of them is Arginine-32 (R32) in the Escherichia coli ADP-Glc PPase. To
explore the overall role of this residue and evaluate the structural and electro-
static importance of the Arginine’s guanidinium group, we replaced it with Ly-
sine (K, -amino group), Alanine (A, - methyl group), Cysteine (C, -sulfide
group), Glutamic (E, - carboxylate group), Glutamine (Q, -amido group) and
Leucine (L, -hydrophobic side chain) via site directed mutagenesis. We over-
expressed the enzymes, purified them to homogeneity, and measured their ki-
netic properties. The Specific Activity (U/mg) for the mutants were as follows:
WT (90.56), R32A (1.65), R32C (0.57), R32E (0.04), R32K (5.81), R32L
(0.65) and R32Q (1.37). Currently, the properties of the R32H (Histidine, -imi-
dizoleum ring) mutant are being investigated. Our results clearly indicate that
this guanidinium group of the Arginine-32 residue is critical for catalysis. Mod-
eling of the E. coli enzyme suggests that the two (2) nitrogen atoms of the gua-
nidinium group may interact with the b and g phosphates of the ATP, helping in
the positioning of the substrates, via electrostatic interactions, and making the
PPi product a more stable leaving group.
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Ubiquitylation is a highly controlled post-translational modification of proteins,
in which proteins are conjugated either with monoubiquitin or polyubiquitin
chains. Ubiquitin modifications on target proteins are recognized by
ubiquitin-binding domains, which are found in several effector proteins. In
this study, we describe the function of the Toll-interacting protein (Tollip),which is an effector protein in the innate immune signaling pathway and an
adaptor protein for endosomal trafficking. We have previously demonstrated
that the central C2 domain of Tollip preferentially interacts with phosphoinosi-
tides and that this association is critical for membrane targeting of the protein.
Remarkably, we found that ubiquitin modulates Tollip’s lipid binding.We have
observed an ubiquitin dose-dependent inhibition of binding of Tollip to phos-
phoinositides and it does so specifically by blocking Tollip C2 domain-
phosphoinositide interactions. This led us to hypothesize that the Tollip C2 do-
main is a novel ubiquitin-binding domain. In addition, we have biophysically
characterized the association of the Tollip CUE domain to ubiquitin and iden-
tified key interacting residues. The Tollip CUE domain reversibly binds ubiq-
uitin with low micromolar affinity at a site that overlaps with that
corresponding to the Tollip C2 domain. We have also found that ubiquitin bind-
ing to dimeric Tollip CUE domain induces a drastic conformational change in
the protein, leading to the formation of a heterodimeric Tollip CUE-ubiquitin
complex. These data suggest that ubiquitin binding to the Tollip C2 and
CUE domain and ubiquitin-mediated dissociation of CUE dimer reduces the af-
finity of the Tollip protein for endosomal phosphoinositides, allowing Tollip
cytoplasmic sequestration. Overall, our findings will provide the structural
and molecular basis to understand how Tollip, as an endocytic adaptor protein,
is modulated by ubiquitin and determines the fate of polyubiquitinated cargo
for endosomal degradation.
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Maintaining membrane proteins at the right place at the right time is crucial
to cellular function. To support such organization a broad spectrum of regu-
lating proteins from the cytosol bind, recruit and arrange the membrane pro-
teins into specific structures. PICK1 is an abundant scaffolding protein
interacting with more than 30 different receptors, transporters and ion chan-
nels, embedded in lipid membranes. PICK1 contains a single N-terminal PDZ
domain and forms homodimers via its central membrane bending and curva-
ture sensing N-BAR domain thus forming a functional unit with two PDZ do-
mains. The PICK1 PDZ domain binds many different PDZ peptide ligands
such as GluA2, mGluR7 and the dopamine transporter with no apparent con-
served binding motif. The wide span of affinities seen for such proteins raises
the question of the importance of the affinity for the isolated domain interac-
tions in context of the overall avidity and the functional effects of these
interactions.
We have established a system based on the previously published supported
membrane sheet system to study the binding of PICK1 to a cell membrane ex-
pressed ligand to determine the avidity for ‘‘on membrane interactions’’. Sec-
ondly, we address the functional effects of lowering the affinity of the PDZ
domain interactions on the functional effects of PICK1.
We demonstrate a dramatic increase in the binding Kd for the oligomeric inter-
action compared to affinities previously reported in non-native condition bind-
ing assays. Furthermore, we show that the interaction is only facilitated by
functional PDZ domain. We also observe a significant change in Bmax for
lower affinity ligands indicating that the increase of the PDZ affinities might
rely on a cooperative binding mechanism of the PICK1 homodimer, which is
consistent with results showing that the homodimer binds tighter than the
monomer.
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A common challenge in biophysical studies of membrane proteins is the choice
of an adequate model membrane or membrane mimetic. Commonly used mi-
metics (detergents, liposomes) often suffer from well known limitations (ad-
verse modification of protein structure, inhomogeneous protein distribution,
etc.), thus prohibiting extensive studies on membrane proteins. However, the
recently developed ‘nanodisc’ membrane mimetic sytem has helped alleviate
some of these shortcomings. Nanodiscs are self assembled proteolipid particles,
wherein two copies of an apolipoprotein A-I derived recombinant membrane
scaffold protein (MSP) clasp a lipid patch, and seal the hydrophobic edge of
the bilayer from water. The incorporation of a membrane protein into the
